Carl Zeiss Meditec (0DHC) Financial Statements
Carl Zeiss Meditec Financial Overview
Carl Zeiss Meditec's market cap is currently $3.13B. The company's EPS TTM is $1.67; its P/E ratio is 20.95; and it has a dividend yield of 1.55%. Carl Zeiss Meditec is scheduled to report earnings on December 10, 2026, and the estimated EPS forecast is $0.46. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.23B | $ 2.07B | $ 2.09B | $ 1.90B | $ 1.65B |
| Gross Profit | $ 1.18B | $ 1.09B | $ 1.21B | $ 1.13B | $ 967.21M |
| Operating Income | $ 223.32M | $ 194.45M | $ 348.12M | $ 396.88M | $ 373.61M |
| EBITDA | $ 346.89M | $ 403.06M | $ 501.88M | $ 482.85M | $ 410.00M |
| Net Income | $ 141.21M | $ 178.73M | $ 290.40M | $ 293.91M | $ 236.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 27.27M | $ 20.29M | $ 10.60M | $ 7.73M | $ 7.44M |
| Total Assets | $ 3.46B | $ 3.39B | $ 3.03B | $ 2.82B | $ 2.40B |
| Total Debt | $ 607.37M | $ 612.73M | $ 297.72M | $ 219.08M | $ 197.17M |
| Net Debt | $ 580.10M | $ 592.44M | $ 287.12M | $ 211.35M | $ 189.73M |
| Total Liabilities | $ 1.33B | $ 1.34B | $ 860.02M | $ 792.73M | $ 718.59M |
| Stockholders' Equity | $ 2.12B | $ 2.04B | $ 2.16B | $ 2.02B | $ 1.66B |
| Cash Flow | |||||
| Free Cash Flow | $ 170.46M | $ 95.11M | $ 137.00M | $ 106.23M | $ 296.56M |
| Operating Cash Flow | $ 209.86M | $ 247.32M | $ 250.86M | $ 188.20M | $ 362.66M |
| Investing Cash Flow | $ -91.03M | $ -412.31M | $ -110.98M | $ -148.89M | $ -75.20M |
| Financing Cash Flow | $ -108.83M | $ 176.25M | $ -135.09M | $ -38.24M | $ -285.89M |
Currency in EUR